SOAT1 enhances lung cancer invasiveness by stimulating AKT-mediated mitochondrial fragmentation

被引:11
|
作者
Mo, Yijun [1 ]
Lin, Lina [2 ]
Zhang, Jianhua [1 ]
Yu, Changhui [3 ]
机构
[1] Southern Med Univ, Shenzhen Hosp, Dept Thorac Surg, Shenzhen 518110, Peoples R China
[2] Guangzhou Xinhua Univ, Sch Nursing, Guangzhou 510520, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Guangzhou, Peoples R China
关键词
lung cancer; invasion; Sterol O-acyltransferase 1; mitochondrial fragmentation; AKT; LIPID-METABOLISM; CHOLESTEROL; INHIBITION; DYNAMICS; TARGET;
D O I
10.1139/bcb-2021-0175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sterol O-acyltransferase 1 (SOAT1) is a key enzyme in lipid metabolism, which mediates cholesterol esterification metabolism and is closely associated with many cancers. However, the role of SOAT1 in lung cancer invasion remains unclear. We found that SOAT1 expression was positively correlated with lung cancer invasion. Downregulation of SOAT1 inhibited invasion, mitochondrial fragmentation, AKT phosphorylation, and phospho-Drp (Ser616) in lung cancer cells and promoted intracellular free cholesterol accumulation. Mechanistically, the AKT phosphorylation inhibitor MK-2206 alleviated both SOAT1 overexpression and high expression-induced mitochondrial fragmentation and lung cancer cell invasion. Furthermore, intracellular free cholesterol accumulation reduced AKT phosphorylation, SREBP1 mRNA expression, cell invasion, and mitochondrial fragmentation in lung cancer cells with high SOAT1 expression. In summary, our findings suggest that SOAT1 promotes lung cancer invasion by activating the PI3K/AKT signaling pathway by downregulating intracellular free cholesterol levels, thereby affecting the regulation of mitochondrial fragmentation.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 50 条
  • [41] Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
    Viglietto, G
    Motti, ML
    Bruni, P
    Melillo, RM
    D'Alessio, A
    Califano, D
    Vinci, F
    Chiappetta, G
    Tsichlis, P
    Bellacosa, A
    Fusco, A
    Santoro, M
    NATURE MEDICINE, 2002, 8 (10) : 1136 - 1144
  • [42] GPD1 inhibits the carcinogenesis of breast cancer through increasing PI3K/AKT-mediated lipid metabolism signaling pathway
    Xia, Zhengchao
    Zhao, Ningming
    Liu, Mingzhou
    Jiang, DanDan
    Gao, Shanjun
    Ma, Peizhi
    Huang, Li
    HELIYON, 2023, 9 (07)
  • [43] Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
    Giuseppe Viglietto
    Maria Letizia Motti
    Paola Bruni
    Rosa Marina Melillo
    Amelia D'Alessio
    Daniela Califano
    Floriana Vinci
    Gennaro Chiappetta
    Philip Tsichlis
    Alfonso Bellacosa
    Alfredo Fusco
    Massimo Santoro
    Nature Medicine, 2002, 8 : 1136 - 1144
  • [44] Novel selenylated imidazo[1,2-a]pyridines for breast cancer chemotherapy: Inhibition of cell proliferation by Akt-mediated regulation, DNA cleavage and apoptosis
    Almeida, Gabriela M.
    Rafique, Jamal
    Saba, Sumbal
    Siminski, Tamila
    Mota, Nadia S. R. S.
    Wilhelm Filho, Danilo
    Braga, Antonio Luiz
    Pedrosa, Rozangela Curi
    Ourique, Fabiana
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1291 - 1297
  • [45] GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT-Mediated EMT
    Xu, En
    Xia, Xuefeng
    Jiang, Chaoyu
    Li, Zijian
    Yang, Zhi
    Zheng, Chang
    Wang, Xingzhou
    Du, Shangce
    Miao, Ji
    Wang, Feng
    Wang, Yizhou
    Lu, Xiaofeng
    Guan, Wenxian
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [46] Akt-mediated transforming growth factor-β1-induced epithelial-mesenchymal transition in cultured human esophageal squamous cancer cells
    Xuan, X.
    Zeng, Q.
    Li, Y.
    Gao, Y.
    Wang, F.
    Zhang, H.
    Wang, Z.
    He, H.
    Li, S.
    CANCER GENE THERAPY, 2014, 21 (06) : 238 - 245
  • [47] CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression
    Jin, Zihui
    Zhao, Lingling
    Chang, Yixin
    Jin, Rongjia
    Hu, Fangyu
    Wu, Shuang
    Xue, Zixuan
    Ma, Yimeng
    Chen, Chenglin
    Zheng, Minghui
    Chang, Yuanyuan
    Jin, Honglei
    Xie, Qipeng
    Huang, Chuanshu
    Huang, Haishan
    CELL DEATH & DISEASE, 2023, 14 (08)
  • [48] CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression
    Zihui Jin
    Lingling Zhao
    Yixin Chang
    Rongjia Jin
    Fangyu Hu
    Shuang Wu
    Zixuan Xue
    Yimeng Ma
    Chenglin Chen
    Minghui Zheng
    Yuanyuan Chang
    Honglei Jin
    Qipeng Xie
    Chuanshu Huang
    Haishan Huang
    Cell Death & Disease, 14
  • [49] Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism
    Li, He
    Li, Jiang-jiang
    Lu, Wenhua
    Yang, Jing
    Xia, Yunfei
    Huang, Peng
    BIOMEDICINES, 2023, 11 (02)
  • [50] Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
    Ko, Jen-Chung
    Syu, Jhan-Jhang
    Chen, Jyh-Cheng
    Wang, Tai-Jing
    Chang, Po-Yuan
    Chen, Chien-Yu
    Jian, Yun-Ting
    Jian, Yi-Jun
    Lin, Yun-Wei
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (06) : 383 - 391